Coloplast A/S (CLPBY) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Instruments & Supplies secteur d'activité. Le siège social de l'entreprise est situé à Humlebæk, Denmark. Le PDG actuel est Lars Soren Rasmussen.
CLPBY a date d'introduction en bourse 2014-01-13, 16,741 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $15.22B.
Coloplast A/S is a Danish healthcare company founded in 1954 that develops and markets intimate healthcare products and services globally, with significant operations in the United States, United Kingdom, France, and Denmark. The company operates through three core segments: Chronic Care, which includes ostomy and continence care products such as SenSura and SpeediCath; Wound & Skin Care, featuring branded solutions like Biatain Silicone and Comfeel dressings; and Interventional Urology, offering products for surgical treatment of urological and gynecological conditions. Coloplast's product portfolio addresses chronic conditions including ostomy management, urinary incontinence, wound care, and skin health through both therapeutic devices and accessories. Headquartered in Humlebæk, Denmark, the company serves patients and healthcare providers worldwide with innovative solutions for conditions such as urinary stone disease, benign prostate hyperplasia, and erectile dysfunction.
